Structures of redox enzymes

Current Opinion in Biotechnology

Volumn 11, Issue 4, 2000, Pages 369-376

  Munro, Andrew W ^a   Taylor, Paul ^b   Walkinshaw, Malcolm D ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CYTOCHROME; FUMARATE REDUCTASE; HALIDE; HALOACID; LIGAND; NITRIC OXIDE SYNTHASE; OXIDOREDUCTASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ELECTRON TRANSPORT; ENZYME STRUCTURE; HUMAN; LIGAND BINDING; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTON TRANSPORT; REVIEW;

BACTERIA (MICROORGANISMS);

EID: 0033898239     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00112-9     Document Type: Review

References (35)

1. Ziegler G.A., Vonrhein C., Hanukoglu I., Schulz G.E. The structure of adrenodoxin reductase of mitochondrial P450 systems: electron transfer for steroid biosynthesis. J Mol Biol. 289:1999;981-990. Adrenodoxin reductase is involved in the biosynthesis of all steroid hormones. The structure provides an insight into the electron transduction pathway in which adrenodoxin reductase recieves two electrons from NADPH and passes them to adrenodoxin. A model for this protein-protein interaction is proposed.
2. Rice D.W., Viner R., Pauptit R.A., Rafferty J.B., Slabas A.R., Stuitje A.R., Camble R., Colls J.G., Mistry A., Minshull C.A.et al. Crystallographic analysis of triclosan bound to enoyl reductase. J Mol Biol. 294:1999;527-535.
3. Roujeinikova A., Levy C.W., Rowsell S., Sedelnikova S., Baker P.J., Minshull C.A., Mistry A., Colls J.G., Camble R., Stuitje A.R.et al. Crystallographic analysis of triclosan bound to enoyl reductase. J Mol Biol. 294:1999;527-535.
4. Stewart M.J., Parikh S., Xiao G.P., Tonge P.J., Kisker C. Structural basis and mechanism of enoyl reductase inhibition by triclosan. J Mol Biol. 290:1999;859-865.
5. Einsle O., Messerschmidt A., Stach P., Bourenkov G.P., Bartunik H.D., Huber R., Kroneck P.M.H. Structure of cytochrome c nitrite reductase. Nature. 400:1999;476-480. This enzyme is a key component of the nitrogen cycle and catalyses the reduction of nitrite to ammonia. The 3D structure was used to provide a reaction mechanism for the transformation of the nitrite. The structure also shows a close-packed arrangement of 10 c-type cytochromes, one of which is unusually coordinated to a lysine.
6. Swanson P.E. Dehalogenases applied to industrial-scale biocatalysis. Curr Opin Biotechnol. 10:1999;365-369.
7. Fetzner S. Bacterial dehalogenation. Appl Microbiol Botechnol. 50:1998;633-657.
8. Newman J., Peat T.S., Richard R., Kan L., Swanson P.E., Affholter J.A., Holmes I.H., Schindler J.F., Unkefer C.J., Terwilliger T.C. Haloalkane dehalogenases: structure of a Rhodococcus enzyme. Biochemistry. 38:1999;16105-16114.
9. Smatanova I., Nagata Y., Svensson L.A., Takagi M., Marek J. Crystallization and preliminary X-ray diffraction analysis of haloalkane dehalogenase LinB from Sphingomonas paucimobilis UT26. Acta Crystallogra D. 55:1999;1231-1233.
10. Li Y-F., Hata Y., Fujii T., Hisano T., Nishihara M., Kurihara T., Esaki N. Crystal structures of reaction intermediates of L-2-haloacid dehalogenase and implications for reaction mechanism. J Biol Chem. 273:1998;15035-15044.
11. Hynkova K., Nagata Y., Takagi M., Damborsky J. Identification of the catalytic triad in the haloalkane dehalogenase from Sphingomonas paucimobilis UT26. FEBS Lett. 446:1999;177-181.
12. Ridder I.S., Rozeboom H.J., Dijkstra B.W. Haloalkane dehalogenase from Xanthobacter autotrophicus GJ10 refined at 1.15 angstrom resolution. Acta Crystallogra D. 55:1999;1273-1290.
13. Ridder I.S., Rozeboom H.J., Kalk K.H., Dijkstra B.W. Crystal structures of intermediates in the dehalogenation of haloalkanoates by L-2-haloacid dehalogenase. J Biol Chem. 274:1999;30672-30678.
14. Iwata S., Lee W., Okada K., Lee J.K., Iwata M., Rasmussen B., Link T.A., Ramaswamy S., Jap B.K. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science. 281:1998;64-71.
15. Xia D., Yu C.A., Kim H., Xian J.Z., Kachurin A.M., Zhang L., Yu L., Deisenhofer J. Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science. 277:1997;60.
16. Crofts A.R., GuergovaKuras M., Huang L.S., Kuras R., Zhang Z.L., Berry E.A. Mechanism of ubiquinol oxidation by the bc1 complex: role of the iron sulfur protein and its mobility. Biochemistry. 38:1999;15791-15806.
17. Yu C.A., Tian H., Zhang L., Deng K.P., Shenoy S.K., Yu L., Xia D., Kim H., Deisenhofer J. Structural basis of multifunctional bovine mitochondrial cytochrome bc1 complex. J Bioenerg Biomembr. 31:1999;191-199.
18. Kim H., Xia D., Yu C.A., Xia J.Z., Kachurin A.M., Zhang L., Yu L., Deisenhofer J. Inhibitor binding changes domain mobility in the iron-sulfur protein of the mitochondrial bc1 complex. Proc Natl Acad Sci USA. 95:1998;8026-8033.
19. Bamford V., Dobbin P.S., Richardson D.J., Hemmings A.M. Open conformation of a flavocytochrome c3 fumarate reductase. Nat Struct Biol. 6:1999;1104-1107. The open conformation of fcc3 in this structure shows the domain movement required to allow the fumarate substrate to enter.
20. Taylor P., Pealing S.L., Reid G.A., Chapman S.K., Walkinshaw M.D. Structural and mechanistic mapping of a unique fumarate reductase. Nat Struct Biol. 6:1999;1108-1112. This high resolution (1.8 Å) structure shows a malate-like intermediate trapped in the active site. Details of the mechanism are deduced from the structure which shows a probable proton pathway used to reduce the fumarate and the involvement of a conserved arginine side-chain acting as the proton donor for fumarate reduction.
21. •]. There are, however, differences in the orientation of the clamp domain that regulates entry to the active site.
22. Lancaster C.R.D., Kroger A., Auer M., Michel H. Structure of fumarate reductase from Wolinella succinogenes at 2.2 angstrom resolution. Nature. 402:1999;377-385. This membrane-bound fumarate reductase shares a similar active site to that of the soluble fcc3 structures. The structure suggests an electron transfer pathway that carries electrons from the quinol-oxidising site in the membrane via two haem groups and three Fe-S clusters to the FAD at the active site.
23. Iversen T.M., Luna Chavez C., Cecchini G., Rees D.C. Structure of the Escherichia coli fumarate reductase respiratory complex. Science. 284:1999;1961-1966. Despite a resolution of only 3.3 Å, the structure of this integral membrane protein showed remarkable detail and many similarities with the soluble fcc3 structures. The electron transfer pathway is similar to that found in Wolinella succinogenes. Two quinone groups are located on opposite sides of the membrane-bound domain.
24. Toyoda T., Suzuki K., Sekiguchi T., Reed L.J., Takenaka A. Crystal structure of eucaryotic E3 lipoamide dehydrogenase from yeast. J Biochem. 123:1998;668-674.
25. Mittl P.R.E., Schulz G.E. Structure of glutathione reductase from Escherichia coli at 1.86 angstrom resolution - comparison with the enzyme from human erythrocytse. Protein Sci. 3:1994;799-809.
26. Mattevi A., Tedeschi G., Bacchella L., Coda A., Negri A., Ronchi S. Structure of L-aspartate oxidase: implications for the succinate dehydrogenase/fumarate reductase oxidoreductase family. Structure. 7:1999;745-756.
27. Wang M., Roberts D.L., Paschke R., Shea T.M., Masters B.S.S., Kim J.J. Three dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc Natl Acad Sci USA. 94:1997;841-8416.
28. Crane B.R., Arvai A.S., Gachhui R., Wu C.Q., Ghosh D.K., Getzoff E.D., Stuehr D.J., Tainer J.A. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science. 278:1997;425-431.
29. Raman C.S., Li H., Martasek P., Kral V., Masters B.S.S., Poulos T.L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell. 95:1998;939-950.
30. Li H., Raman C.S., Glaser C.B., Blasko E., Young T.A., Parkinson J.F., Whitlow M., Poulos T.L. Crystal structures of zinc-free and -bound heme domain of human inducible nitric oxide synthase. J Biol Chem. 274:1999;21276-21284. Crucially, these structures show that pterin binding does not stabilise the dimer interface. In the presence of zinc, four cysteine residues form a zinc-tetrathiolate complex which stabilises the dimer. In the absence of zinc, two symmetry related cysteines form disulfide bonds.
31. Crane B.R., Arvai A.S., Ghosh D.K., Wu C., Getzoff E.D., Stuehr D.J., Tainer J.A. Structure of nitric oxides synthase dimer with pterin and substrate. Science. 279:1998;2121-2126.
32. Fischmann T.O., Hruza A., Niu X.D., Fossetta J.D., Lunn C.A., Dolphin E., Prongay A.J., Reichert P., Lundell D.J., Narula S.K., Weber P.C. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol. 6:1999;233-242. Crystal structures of the catalytic domains of human endothelial nitric oxide synthase and human inducible NOS were solved as complexes with arginine and S-ethylisothiourea. Despite strong similarities hopes are kept alive for the design of isozyme-selective inhibitors.
33. Crane B.R., Rosenfeld R.J., Arvai A.S., Ghosh D.K., Ghosh S., Tainer J.A., Stuehr D.J., Getzoff E.D. N-terminal domain swapping and metal ion binding in nitric oxide synthase dimerization. EMBO J. 18:1999;6271-6281. The role of cysteine residues is explored in stabilisation of the dimer interface. In the presence of zinc a zinc-thiolate complex is formed at the dimer interface.
34. Williams P.A., Cosme J., Sridhar V., Johnson E.F., McRee D.E. Mammalian microsomal P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol Cell. 5:2000;121-131.
35. Schlichting I., Berendzen J., Chu K., Stock A.M., Maves S., Benson D.E., Sweet R.M., Ringe D., Petsko G.A., Sligar S.G. The catalytic pathway of cytochrome P450cam at atomic resolution. Science. 287:2000;1615-1622.